Mike Matson

Q: What is Mike Matson's success rate?

Mike Matson currently has a success rate of 90.85711971296583.

Q: What is the average return of Mike Matson's calls?

Their stock ratings have generated an average return of 18.113729182908827.

Needham | Healthcare

Mike Matson is an analyst from Needham specializing in the Healthcare sector. Ranked #1391 out of 4773 analysts, they have issued 77 stock ratings with a success rate of 90.86% and an average return of 18.11%.

Mike Matson has a well-established track record, with 77 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 90.86% and an average return of 18.11%, underscoring their expertise and ability to identify winning opportunities for investors.

#1391

Out of 4773

Total Ratings

+90.86%

Success Rate

+18.11%

Average Return

Recent Ratings Analysis

MDT

Buy

Sep 01, 2026

Target

$114.00

Current

$90.96

Performance

-1.17%

Mike Matson rated MDT as Buy on Sep 01, 2026, setting a price target of 114. Shares have remained stable near 90.96, leaving the 114 target still in play.

LIVN

Buy

Aug 05, 2026

Target

$93.00

Current

$78.18

Performance

0.04%

On Aug 05, 2026, LIVN was given a Buy rating by Mike Matson, with a target price of 93. The stock traded sideways with a 0.04% move, keeping the bullish thesis unresolved.

KIDS

Buy

Aug 05, 2026

Target

$35.00

Current

$22.06

Performance

-1.12%

KIDS received a Buy rating from Mike Matson on Aug 05, 2026, aiming for 35. Price action was muted, as shares hovered around 22.06 despite the bullish outlook.

TMDX

Buy

Aug 03, 2026

Target

$106.00

Current

$82.18

Performance

0.77%

On Aug 03, 2026, Mike Matson published a Buy outlook on TMDX, with a target of 106. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 82.18.

MMSI

Buy

Jul 31, 2026

Target

$101.00

Current

$86.36

Performance

1.59%

Mike Matson on Jul 31, 2026 assigned MMSI a Buy rating, with a price target of 101. The recommendation remains pending validation as shares consolidate around 86.36.

VCYT

Buy

Jul 31, 2026

Target

$69.00

Current

$40.87

Performance

-11.77%

On Jul 31, 2026, Mike Matson reaffirmed VCYT with a Buy rating, targeting 69. Shares slid 11.77% despite the recommendation, highlighting downside risks.

TFX

Buy

Jul 31, 2026

Target

$159.00

Current

$130.99

Performance

-4.18%

TFX was rated Buy by Mike Matson on Jul 31, 2026, with a price objective of 159. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

NEO

Buy

Jul 29, 2026

Target

$19.00

Current

$17.32

Performance

13.43%

On Jul 29, 2026, Mike Matson initiated coverage on NEO with a Buy rating and target of 19. The stock’s climb of 13.43% since the call highlights the foresight in the rating.

AORT

Buy

Jul 20, 2026

Target

$44.00

Current

$25.08

Performance

-1.14%

Mike Matson issued a Buy recommendation for AORT on Jul 20, 2026, price target set at 44. The target of 44 remains in play, though confirmation will depend on future moves.

PSNL

Buy

Jul 17, 2026

Target

$17.00

Current

$16.21

Performance

5.33%

On Jul 17, 2026, PSNL was evaluated by Mike Matson, who gave a Buy rating and target of 17. This case illustrates how a timely bullish rating can translate into tangible gains of 5.33%.

BSX

Buy

Jul 08, 2026

Target

$57.00

Current

$42.98

Performance

-4.08%

Mike Matson rated BSX as Buy on Jul 08, 2026, setting a price target of 57. Shares have remained stable near 42.98, leaving the 57 target still in play.

ICUI

Buy

May 27, 2026

Target

$165.00

Current

$156.48

Performance

13.11%

On May 27, 2026, ICUI was given a Buy rating by Mike Matson, with a target price of 165. The stock rallied 13.11% after the rating, narrowing the gap to the target of 165 and validating the bullish stance.

SYK

Buy

May 01, 2026

Target

$418.00

Current

$275.56

Performance

—

SYK received a Buy rating from Mike Matson on May 01, 2026, aiming for 418. Price action was muted, as shares hovered around 275.56 despite the bullish outlook.

LUCD

Buy

Mar 26, 2026

Target

$3.00

Current

$0.78

Performance

—

On Mar 26, 2026, Mike Matson published a Buy outlook on LUCD, with a target of 3. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 0.7829.

ENOV

Buy

Feb 26, 2026

Target

$52.00

Current

$19.28

Performance

-24.15%

Mike Matson on Feb 26, 2026 assigned ENOV a Buy rating, with a price target of 52. The call has struggled to gain traction, with shares losing 24.15%.

ESTA

Buy

Feb 24, 2026

Target

$86.00

Current

$70.94

Performance

-10.96%

On Feb 24, 2026, Mike Matson reaffirmed ESTA with a Buy rating, targeting 86. Shares slid 10.96% despite the recommendation, highlighting downside risks.

ATRC

Buy

Feb 12, 2026

Target

$45.00

Current

$54.54

Performance

71.51%

ATRC was rated Buy by Mike Matson on Feb 12, 2026, with a price objective of 45. A bullish response from the market helped close the gap of -9.54 to the target.

ZBH

Hold

Feb 10, 2026

Target

—

Current

$93.49

Performance

2.29%

On Feb 10, 2026, Mike Matson initiated coverage on ZBH with a Hold rating and target of null. The stock’s lack of movement around 93.49 aligned with a cautious approach.

CNMD

Hold

Jan 29, 2026

Target

—

Current

$46.30

Performance

24.10%

Mike Matson issued a Hold recommendation for CNMD on Jan 29, 2026, price target set at null. A neutral call gave way to stronger-than-expected performance, closing in on null.

PEN

Hold

Jan 16, 2026

Target

—

Current

$317.73

Performance

-9.42%

On Jan 16, 2026, PEN was evaluated by Mike Matson, who gave a Hold rating and target of null. The Hold call avoided chasing into subsequent weakness of 9.42%.

HAE

Hold

Dec 15, 2025

Target

—

Current

$102.69

Performance

27.72%

Mike Matson rated HAE as Hold on Dec 15, 2025, setting a price target of null. Despite the Hold call, shares climbed 27.72% to 102.69, revealing unexpected momentum.

IMDX

Buy

Nov 11, 2025

Target

$9.00

Current

$4.20

Performance

-44.22%

On Nov 11, 2025, IMDX was given a Buy rating by Mike Matson, with a target price of 9. Despite the Buy call, shares fell from 4.2 to 4.2, challenging the optimistic stance.

HOLX

Hold

Oct 21, 2025

Target

—

Current

$76.01

Performance

2.74%

HOLX received a Hold rating from Mike Matson on Oct 21, 2025, aiming for null. Shares remained flat at 76.01, aligning with the neutral rating.

INMD

Hold

Oct 10, 2025

Target

—

Current

$14.90

Performance

-2.42%

On Oct 10, 2025, Mike Matson published a Hold outlook on INMD, with a target of null. Sideways action left the Hold view intact, with no major move since 14.9.

MASI

Hold

Apr 10, 2025

Target

—

Current

$179.95

Performance

18.79%

Mike Matson on Apr 10, 2025 assigned MASI a Hold rating, with a price target of null. Shares outperformed expectations, climbing 18.79% despite the neutral view.

INGN

Hold

Apr 09, 2025

Target

—

Current

$5.31

Performance

-24.57%

On Apr 09, 2025, Mike Matson reaffirmed INGN with a Hold rating, targeting null. The Hold stance reflected market caution that was later justified.

OCX

Buy

Apr 08, 2025

Target

$4.25

Current

$3.20

Performance

16.36%

OCX was rated Buy by Mike Matson on Apr 08, 2025, with a price objective of 4.25. A bullish response from the market helped close the gap of 1.05 to the target.

STE

Hold

Apr 07, 2025

Target

—

Current

$210.76

Performance

-0.94%

On Apr 07, 2025, Mike Matson initiated coverage on STE with a Hold rating and target of null. The stock’s lack of movement around 210.76 aligned with a cautious approach.

RMD

Hold

Jan 31, 2025

Target

—

Current

$218.27

Performance

-7.58%

Mike Matson issued a Hold recommendation for RMD on Jan 31, 2025, price target set at null. Market action validated the conservative Hold outlook with shares at 218.27.

SRDX

Hold

Jan 30, 2025

Target

—

Current

$42.98

Performance

21.14%

On Jan 30, 2025, SRDX was evaluated by Mike Matson, who gave a Hold rating and target of null. Investors who stayed in despite the Hold saw upside of 21.14%.

FNA

Hold

Jan 29, 2025

Target

$13.00

Current

$13.09

Performance

0.77%

Mike Matson rated FNA as Hold on Jan 29, 2025, setting a price target of 13. The Hold stance appears justified, as shares hovered around 13.09 with a 0.77% move.

NARI

Hold

Oct 09, 2024

Target

—

Current

$79.97

Performance

91.82%

On Oct 09, 2024, NARI was given a Hold rating by Mike Matson, with a target price of null. The stock rallied from 79.97 to 79.97 after the Hold rating, surprising to the upside.

AXNX

Hold

May 06, 2024

Target

—

Current

$70.98

Performance

5.02%

AXNX received a Hold rating from Mike Matson on May 06, 2024, aiming for null. Investors saw gains of 5.02% that the cautious stance didn’t fully capture.

Frequency Asked Questions

Who is Mike Matson?

Mike Matson is an analyst from Needham specializing in the Healthcare sector.

What is Mike Matson's success rate?

Mike Matson currently has a success rate of +90.86%.

How many ratings has Mike Matson issued?

Mike Matson has issued 77 stock ratings so far.

What is the average return of Mike Matson's calls?

Their stock ratings have generated an average return of +18.11%.

What is Mike Matson's ranking?

Mike Matson is ranked #1391 out of 4773 analysts.

What types of ratings does Mike Matson give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Mike Matson?

You can follow Mike Matson by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Mike Matson?

Their latest rating was a Buy on MDT issued on 2026-09-01.